[go: up one dir, main page]

AU2002255445A1 - Diagnosis of cancer using eif3 as a marker - Google Patents

Diagnosis of cancer using eif3 as a marker

Info

Publication number
AU2002255445A1
AU2002255445A1 AU2002255445A AU2002255445A AU2002255445A1 AU 2002255445 A1 AU2002255445 A1 AU 2002255445A1 AU 2002255445 A AU2002255445 A AU 2002255445A AU 2002255445 A AU2002255445 A AU 2002255445A AU 2002255445 A1 AU2002255445 A1 AU 2002255445A1
Authority
AU
Australia
Prior art keywords
eif3
marker
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002255445A
Other languages
English (en)
Inventor
Charles A. Nicolette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2002255445A1 publication Critical patent/AU2002255445A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2002255445A 2001-12-05 2001-12-05 Diagnosis of cancer using eif3 as a marker Withdrawn AU2002255445A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/047997 WO2003050543A1 (fr) 2001-12-05 2001-12-05 Diagnostic du cancer au moyen de l'eif-3 utilise comme marqueur

Publications (1)

Publication Number Publication Date
AU2002255445A1 true AU2002255445A1 (en) 2003-06-23

Family

ID=21743112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002255445A Withdrawn AU2002255445A1 (en) 2001-12-05 2001-12-05 Diagnosis of cancer using eif3 as a marker

Country Status (2)

Country Link
AU (1) AU2002255445A1 (fr)
WO (1) WO2003050543A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012910A1 (fr) * 2003-07-31 2005-02-10 The Secretary Of State For Environment, Food & Rural Affairs Antigene peptidique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI108301B (fi) * 1998-12-16 2001-12-31 Finnish Immunotechnology Ltd Diagnostinen menetelmä
CA2410865A1 (fr) * 2000-05-31 2001-12-06 Genzyme Corporation Composes therapeutiques pour le cancer de l'ovaire

Also Published As

Publication number Publication date
WO2003050543A1 (fr) 2003-06-19

Similar Documents

Publication Publication Date Title
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AU2002344354A1 (en) Inhalation capsules
AU2002353739A1 (en) Therapeutic compounds
AU2002365093A1 (en) Therapeutic compositions
AU2002255445A1 (en) Diagnosis of cancer using eif3 as a marker
AU2002302569A1 (en) Antiperspirant formulations
AU2001231192A1 (en) Mob-5/hmob-5 as a cancer diagnostic marker
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2002228190A1 (en) Marker for roscovitine
AU2002342940A1 (en) New pharmaceutical compounds
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002361450A1 (en) Novel pharmaceutical
AU2002232179A1 (en) Novel disease marker
AU2002359381A1 (en) Hip1 cancer markers
AU2002357226A1 (en) The total synthesis of merrilactone a
GB0125764D0 (en) Diagnosis of cervicasl cancer
AUPR743101A0 (en) A cancer therapeutic
AUPR809601A0 (en) Reflective marker
AU2002301360A1 (en) Reflective Marker
AUPR394201A0 (en) Precise medicine
AU2002337330A1 (en) Diagnosis of cervical cancer
AU2002323900A1 (en) Sustained-release medicinal compositions
HK1064959A (en) Therapeutical vaccination
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002300245A1 (en) Endplate preparation instrument

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant